admin

admin

AACR: Advances in Precision Medicine to Continue

Srivani Ravoori, PhD, Associate Director, Science Communications; American Association for Cancer Research Intro: The American Association for Cancer Research (AACR) publishes a forecast blog post at the start of each year to ask prominent cancer research leaders what they envision the new developments will be in areas like immunotherapy, precision medicine, cancer prevention, and health disparities. […]

Why the 21st Century Cures Act is a Good Thing

Mary Woolley, President and CEO of Research!America Follow David Q: You attended the December signing by President Obama of the 21st Century Cures Act and are recognized to be a strong supporter. Yet harsh criticism of it has quickly appeared in JAMA, BMJ, a variety of other venues, as well as on these pages. Please tell […]

Best Uses of PM&R in Patients with Cancer

Val Jones, MD, Medical Director of Admissions, Saint Luke’s Rehabilitation Institute, Spokane, WA Follow Val Q: Your principal practice in Spokane, Washington is Physical Medicine and Rehabilitation. What do you find to be the best uses of PM&R in patients with cancer at your facility? A: Rehabilitation medicine is one of the best-kept secrets in […]

The Importance of Clinical Trial Matching

Adrienne Craig-Kennard, MBA, VP Global Business Development & Strategic Alliances at CollabRx Follow David Q: You have served as Vice President, Global Business Development and Strategic Alliances of CollabRx for more than one year. How do you rank the importance of the CollabRx Clinical Trial Matcher in the “big picture” of cancer care? A: Thousands […]

The Autopsy is Essential in Proper Cancer Care

David S. Priemer, M.D., Resident Physician in Anatomic Pathology and Neuropathology, Indiana University School of Medicine Department of Pathology and Laboratory Medicine, Indianapolis, IN; priemerd@iu.edu Follow David Q: The numbers show that American physicians are ready to cast the medical/hospital autopsy into some relic or trash bin. Yet some physicians believe that the low tech […]

The Future of Nursing Care for Advanced Cancer Patients

Karen Donelan, ScD, EdM, Senior Scientist in Health Policy, Mongan Institute Health Policy Center, Massachusetts General Hospital; Associate Professor of Medicine, Harvard Medical School Boston, MA 02114; kdonelan@mgh.harvard.edu Q: You have gained remarkable insights into the American nursing profession by performing and publishing survey research for many years. What do you envision as the major […]

21st Century Cures Act, Societal Net Negative or Positive?

Daniel R. Hoffman, Ph.D., Health Care Consultant in Glenmoore, PA. Q: Many people are praising the recently passed 21st Century Cures Act. But there are also critics. What are some of the downsides that the American public might experience from this important piece of legislation? A: On December 13 President Obama signed into law the […]

The Role of the NCQA in Advancing Cancer Care

Margaret E. O’Kane, MHA. Founder and President, National Committee for Quality Assurance (NCQA) Washington, DC. Q: Under your visionary leadership, the National Committee for Quality Assurance (NCQA) has established and enforced quality standards for much of American medicine for >25 years. What is the current major role of NCQA in caring for patients with advanced […]

Clinical Trial Matching for Patients with Molecularly Characterized Tumors

Smruti Vidwans, PhD, Chief Science Officer at CollabRx Q: Clinical Trials is such an important topic, but it is so broad. Is there a way to provide better matching for Clinical Trials involving cancer patients, especially those whose cancers may have the added diagnostic information of molecular profiling? A: Clinical trials provide cancer patients, especially […]

Complementary/Alternative Approaches in Advanced Cancer

Marc S. Micozzi, MD, PhD, Editor of Fundamentals of Complementary & Alternative Medicine, 5th ed. (2015), Elsevier Health Sciences, 759 pp; Editor of Complementary and Integrative Medicine in Cancer and Prevention: Foundations and Evidence-Based Interventions (2007), New York: Springer, 478 pp. www.drmicozzi.com Q: Many, even millions, of Americans are living with advanced cancer. You are […]